NCT06786130 Societal Burden Associated With Type 1 Diabetes in Canada
| NCT ID | NCT06786130 |
| Status | Recruiting |
| Phase | — |
| Sponsor | PeriPharm |
| Condition | Type 1 Diabetes Mellitus |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-01-09 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-01-09 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this observational study is to estimate the burden of T1D on caregivers of patient with T1D in terms of work productivity, healthcare resource utilization and quality of life.
Eligibility Criteria
Inclusion Criteria: 1. Parental caregiver of a child recently diagnosed (\<= 2 years) with T1D before study inclusion; 2. Age ≥18 ; 3. Residence in the Canada; 4. Willingess to complete a 20-minute survey 5. Ability to read and understand French or English; 6. Signature of informed consent form (ICF) Exclusion Criteria: 1\. Participation in a clinical trial.
Frequently Asked Questions
Who can join the NCT06786130 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Type 1 Diabetes Mellitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06786130 currently recruiting?
Yes, NCT06786130 is actively recruiting participants. Visit ClinicalTrials.gov or contact PeriPharm to inquire about joining.
Where is the NCT06786130 trial being conducted?
This trial is being conducted at Montreal, Canada.
Who is sponsoring the NCT06786130 clinical trial?
NCT06786130 is sponsored by PeriPharm. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.